# OnCo record paper-olympiad-ann-oncol-2019-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-olympiad-ann-oncol-2019-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-olympiad-ann-oncol-2019-update" ;
  schema:name "OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer"@en ;
  schema:description "Later report from the OlympiAD trial registered as NCT02000622, in Annals of Oncology (2019); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-olympiad-ann-oncol-2019-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1093/annonc/mdz012>, <https://pubmed.ncbi.nlm.nih.gov/30689707/>, <https://europepmc.org/article/MED/30689707>, <https://clinicaltrials.gov/study/NCT02000622> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1093/annonc/mdz012> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Robson ME, Tung N, Conte P, et al." ;
  onco:trials <https://onco.cc/trials/olympiad/> ;
  onco:journals <https://onco.cc/journals/annals-of-oncology/> .